229 related articles for article (PubMed ID: 16594577)
41. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
Peterson GE
Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
[TBL] [Abstract][Full Text] [Related]
42. Feline diabetes mellitus: diagnosis, treatment, and monitoring.
Rios L; Ward C
Compend Contin Educ Vet; 2008 Dec; 30(12):626-39; quiz 639-40. PubMed ID: 19140103
[TBL] [Abstract][Full Text] [Related]
43. Diabetes mellitus in cats.
Rand JS; Marshall RD
Vet Clin North Am Small Anim Pract; 2005 Jan; 35(1):211-24. PubMed ID: 15627634
[TBL] [Abstract][Full Text] [Related]
44. Insulin glargine: a new long-acting insulin product.
Reinhart L; Panning CA
Am J Health Syst Pharm; 2002 Apr; 59(7):643-9. PubMed ID: 11944604
[TBL] [Abstract][Full Text] [Related]
45. The management of diabetes mellitus in cats and dogs.
Veitch ER
J Small Anim Pract; 1972 Nov; 13(11):629-33. PubMed ID: 4648351
[No Abstract] [Full Text] [Related]
46. Insulin glargine has a long duration of effect following administration either once daily or twice daily in divided doses in healthy cats.
Marshall RD; Rand JS; Morton JM
J Feline Med Surg; 2008 Oct; 10(5):488-94. PubMed ID: 18703367
[TBL] [Abstract][Full Text] [Related]
47. Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs.
Hulsebosch SE; Pires J; Bannasch MJ; Lancaster T; Delpero A; Ragupathy R; Murikipudi S; Zion T; Gilor C
J Vet Intern Med; 2022 Jul; 36(4):1211-1219. PubMed ID: 35621084
[TBL] [Abstract][Full Text] [Related]
48. Management of feline diabetes mellitus.
Rand JS; Martin GJ
Vet Clin North Am Small Anim Pract; 2001 Sep; 31(5):881-913. PubMed ID: 11570131
[TBL] [Abstract][Full Text] [Related]
49. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
Ashwell SG; Gebbie J; Home PD
Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
[TBL] [Abstract][Full Text] [Related]
50. Owner experiences in treating dogs and cats diagnosed with diabetes mellitus in the United States.
Aptekmann KP; Armstrong J; Coradini M; Rand J
J Am Anim Hosp Assoc; 2014; 50(4):247-53. PubMed ID: 24855090
[TBL] [Abstract][Full Text] [Related]
51. Selected topics in the management of diabetes mellitus in cats.
Nelson RW
J Feline Med Surg; 2000 Jun; 2(2):101-4. PubMed ID: 11716601
[No Abstract] [Full Text] [Related]
52. Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.
Roomp K; Rand J
J Feline Med Surg; 2012 Aug; 14(8):566-72. PubMed ID: 22553309
[TBL] [Abstract][Full Text] [Related]
53. In cats with newly diagnosed diabetes mellitus, use of a near-euglycemic management paradigm improves remission rate over a traditional paradigm.
Nack R; DeClue AE
Vet Q; 2014; 34(3):132-6. PubMed ID: 24964071
[TBL] [Abstract][Full Text] [Related]
54. Insulin glargine: an updated review of its use in the management of diabetes mellitus.
Dunn CJ; Plosker GL; Keating GM; McKeage K; Scott LJ
Drugs; 2003; 63(16):1743-78. PubMed ID: 12904090
[TBL] [Abstract][Full Text] [Related]
55. Use of a high-protein diet in the management of feline diabetes mellitus.
Frank G; Anderson W; Pazak H; Hodgkins E; Ballam J; Laflamme D
Vet Ther; 2001; 2(3):238-46. PubMed ID: 19746667
[TBL] [Abstract][Full Text] [Related]
56. More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus.
Polonsky W; Traylor L; Wei W; Shi R; Ameer B; Vlajnic A; Nicolucci A
Diabetes Obes Metab; 2014 Mar; 16(3):255-61. PubMed ID: 24028669
[TBL] [Abstract][Full Text] [Related]
57. Comparison of serum fructosamine and blood glycosylated hemoglobin concentrations for assessment of glycemic control in cats with diabetes mellitus.
Elliott DA; Nelson RW; Reusch CE; Feldman EC; Neal LA
J Am Vet Med Assoc; 1999 Jun; 214(12):1794-8. PubMed ID: 10382020
[TBL] [Abstract][Full Text] [Related]
58. Intramuscular glargine with or without concurrent subcutaneous administration for treatment of feline diabetic ketoacidosis.
Marshall RD; Rand JS; Gunew MN; Menrath VH
J Vet Emerg Crit Care (San Antonio); 2013; 23(3):286-90. PubMed ID: 23530935
[TBL] [Abstract][Full Text] [Related]
59. Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.
Duckworth W; Davis SN
J Diabetes Complications; 2007; 21(3):196-204. PubMed ID: 17493554
[TBL] [Abstract][Full Text] [Related]
60. Glargine versus regular insulin protocol in feline diabetic ketoacidosis.
Zeugswetter FK; Luckschander-Zeller N; Karlovits S; Rand JS
J Vet Emerg Crit Care (San Antonio); 2021 Jul; 31(4):459-468. PubMed ID: 33945208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
